Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
26.24 EUR
-0.04%
Market Closed
Updated:
Apr 19, 2024
Bayer AG
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Bayer AG
Operating Income Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Operating Income
€8.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Operating Income
$-125.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Operating Income
€4.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Operating Income
€-975.1k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Operating Income
€201m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Operating Income
€17.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Operating Income?
Operating Income
8.4B
EUR
8.4B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Operating Income amounts to 8.4B EUR.
What is Bayer AG's Operating Income growth rate?
Operating Income CAGR 10Y
5%
5%
Over the last year, the Operating Income growth was 6%.
You don't have any saved screeners yet
